Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group

Published:2016-12-26 Issue:7 Volume:64 Page:e26394
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Friedman Debra L.¹²,Krailo Mark³⁴,Villaluna Doojduen⁴,Gombos Dan⁵,Langholz Bryan³⁴,Jubran Rima⁶,Shields Carol⁷,Murphree Linn³⁶,O'Brien Joan⁸,Kessel Sandra⁹,Rodriguez-Galindo Carlos¹⁰,Chintagumpala Murali¹¹¹²,Meadows Anna T.¹³

Affiliation:

1. Division of Pediatric Hematology/Oncology; Vanderbilt University School of Medicine; Nashville Tennessee

2. Vanderbilt-Ingram Cancer Center; Nashville Tennessee

3. University of Southern California; Los Angeles California

4. Children's Oncology Group; Monrovia California

5. MD Anderson Cancer Center; Houston Texas

6. Children's Hospital of Los Angeles; Los Angeles California

7. Wills Eye Hospital; Philadelphia Pennsylvania

8. University of Pennsylvania; Philadelphia Pennsylvania

9. Imaging and Radiation Oncology Core; Lincoln Rhode Island

10. St. Jude Children's Research Hospital; Memphis Tennessee

11. Texas Children's Hospital; Houston Texas

12. Baylor School of Medicine; Houston Texas

13. The Children's Hospital of Philadelphia; Philadelphia Pennsylvania

Funder

National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.26394/fullpdf

Reference47 articles.

1. Incidence of retinoblastoma in the USA: 1975-2004;Broaddus;Br J Ophthalmol,2009

2. Survival with retinoblastoma in the USA: 1975-2004;Broaddus;Br J Ophthalmol,2009

3. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy;Shields;Curr Opin Ophthalmol,2010

4. Visual fields in retinoblastoma survivors;Abramson;Arch Ophthalmol,2004

5. Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up;Marees;J Natl Cancer Inst,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal Comparison of Orbital Volumes from Enucleated Eyes with Hydroxyapatite Orbital Implant in Unilateral Retinoblastoma Patients;Ophthalmic Plastic & Reconstructive Surgery;2023-11-15

2. Children's Oncology Group's 2023 blueprint for research: Rare tumors;Pediatric Blood & Cancer;2023-07-17

3. How we approach conservative treatment of retinoblastoma in South America in the era of local ocular treatments: A consensus of the Grupo America Latina de Oncologia Pediatrica (GALOP);Pediatric Blood & Cancer;2023-04-14

4. The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma;Cancer Research and Treatment;2023-01-15

5. Children’s Oncology Group Trials in Retinoblastoma;Global Perspectives in Ocular Oncology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3